Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Development of Targeted RNA-Seq for Amyotrophic Lateral Sclerosis Diagnosis — Stella

Home/Amyotrophic Lateral Sclerosis/

View on ClinicalTrials.gov

Recruiting

Back to Amyotrophic Lateral Sclerosis trials

Trial locations(7 sites)

France

CHU de Bordeaux, Bordeaux

CHU de Clermont-Ferrand, Clermont-Ferrand

CHU de Lyon, Lyon

La Timone, Marseille

CHU de Montpellier, Montpellier

CHU de Nîmes, Nîmes

CHU de Toulouse, Toulouse

Key details

Sponsor

Centre Hospitalier Universitaire de Nīmes

Collaborators

Association pour la Recherche sur la Sclérose Latérale Amyotrophique et autres maladies du motoneurones

Enrollment target

~192 participants

Started

November 2023

Primary completion

May 2027

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.